Cancer Health Treatment Update The New Palliative Care This team-based approach can ease symptoms and improve quality of life for anyone living with cancer at any stage. For Women with Breast Cancer, Regular Exercise May Improve Survival The bottom-line message for breast cancer survivors is “move as often as you can, when you can.” FDA Approves Tecentriq for First-Line Treatment of Metastatic Lung Cancer Initial treatment with atezolizumab led to longer overall survival in people with high biomarker levels. How Climate Change Impacts the Cancer Fight A group of oncologists has advised colleagues to join the fight against climate change. For all of Cancer Health's coverage of the novel coronavirus and COVID-19, click here. Researchers to Test Blood Cancer Drug in COVID-19 Patients A clinical trial will test whether Imbruvica can protect against respiratory problems caused by the virus. Financial Lifelines for People With Cancer During the Pandemic Family Reach has helped people with cancer pay their bills for 25 years. Due to the coronavirus pandemic, it’s reinventing how it does so. Cancer Health Spring 2020 Check out our new print edition! Advertisement Newsfeed Financial Lifelines for People With Cancer During the Pandemic How Climate Change Impacts the Cancer Fight Do Suntans Really Protect Against Burns That Cause Skin Cancer? Johnson & Johnson Ends North American Sales of Talc-Based Baby Powder Blog: Food and Drug Administration (FDA) FDA Approves Qinlock for Fourth-Line Treatment of Advanced Gastrointestinal Stromal Tumors FDA Approves Tecentriq for First-Line Treatment of Metastatic Lung Cancer FDA Approves Opdivo Plus Yervoy for Lung Cancer With PD-L1 Expression FDA Approves Lynparza Plus Bevacizumab for Ovarian Cancer Maintenance Treatment Newsfeed Financial Lifelines for People With Cancer During the Pandemic How Climate Change Impacts the Cancer Fight Do Suntans Really Protect Against Burns That Cause Skin Cancer? Johnson & Johnson Ends North American Sales of Talc-Based Baby Powder Blog: Food and Drug Administration (FDA) FDA Approves Qinlock for Fourth-Line Treatment of Advanced Gastrointestinal Stromal Tumors FDA Approves Tecentriq for First-Line Treatment of Metastatic Lung Cancer FDA Approves Opdivo Plus Yervoy for Lung Cancer With PD-L1 Expression FDA Approves Lynparza Plus Bevacizumab for Ovarian Cancer Maintenance Treatment

You are receiving this email because you opted in at one of our websites. At your request, this message was sent to newsletter@newslettercollector.com by update@cancerhealth.com. Please remember to add update@cancerhealth.com to your email address book, so that these updates aren't blocked as spam.

To change your subscription information and preferences, please visit your personal preferences page. Or you can unsubscribe completely from this list.

To forward this message, please do not use the forward button of your email application, because this message was made specifically for you only. Instead use the forward page in our newsletter system.

Did you receive this email from a friend? You can subscribe and you will receive our next newsletter directly to your inbox.

Our mailing address is: